Preliminary tests of a highly attenuated measles vaccine
- PMID: 13909753
- DOI: 10.1001/archpedi.1962.02080020398042
Preliminary tests of a highly attenuated measles vaccine
Similar articles
-
[Experience in vaccinatkon with attenuated measles vaccine. I. Preliminary report on clinical aspects].Pediatria (Santiago). 1962 May-Jun;5:223-32. Pediatria (Santiago). 1962. PMID: 14472599 Spanish. No abstract available.
-
[Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin].Harefuah. 1962 Sep 2;63:161-6. Harefuah. 1962. PMID: 14464579 Hebrew. No abstract available.
-
Attenuated live measles vaccine.Am J Pharm Sci Support Public Health. 1961 Aug;133:278-93. Am J Pharm Sci Support Public Health. 1961. PMID: 13898053 No abstract available.
-
[Current problems in measles. II. Measles vaccines--recent progress].Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1984 Jul-Sep;29(3):259-78. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1984. PMID: 6438773 Review. Romanian. No abstract available.
-
Measles control: so near and yet so far.Prog Med Virol. 1985;31:1-42. Prog Med Virol. 1985. PMID: 3881804 Review. No abstract available.
Cited by
-
Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.J Virol. 2001 Jan;75(2):921-33. doi: 10.1128/JVI.75.2.921-933.2001. J Virol. 2001. PMID: 11134305 Free PMC article.
-
Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.J Virol. 2015 Feb;89(4):2192-200. doi: 10.1128/JVI.02924-14. Epub 2014 Dec 3. J Virol. 2015. PMID: 25473055 Free PMC article.
-
Antitumor Virotherapy by Attenuated Measles Virus (MV).Biology (Basel). 2013 Mar 28;2(2):587-602. doi: 10.3390/biology2020587. Biology (Basel). 2013. PMID: 24832799 Free PMC article.
-
STUDIES ON KILLED AND ATTENUATED MEASLES VACCINES IN GENERAL PRACTICE.Br Med J. 1965 Jul 3;2(5452):13-6. doi: 10.1136/bmj.2.5452.13. Br Med J. 1965. PMID: 14305344 Free PMC article. No abstract available.
-
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.J Virol. 2024 May 14;98(5):e0176223. doi: 10.1128/jvi.01762-23. Epub 2024 Apr 2. J Virol. 2024. PMID: 38563762 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources